倍杰特(300774.SZ)聯合體中標10.74億元項目
格隆匯10月7日丨倍杰特(300774.SZ)公佈,2024年9月29日,中國政府採購網(http://www.ccgp.gov.cn/)發佈《喀什市水利局喀什地區喀什市城北供水保障能力提升工程及污水處理廠建設項目中標公吿》,公司與中建新疆建工(集團)有限公司組成的聯合體為喀什地區喀什市城北供水保障能力提升工程及污水處理廠建設項目的供應商。
此次中標項目是公司在在新疆地區進行工業廢水資源化、鹽湖及礦山開發等戰略佈局的階段性成果。此次中標項目金額為107400.00萬元(含税),佔公司2023年度經審計營業收入的164.45%,預計將對公司未來經營業績產生積極影響,本項目正式合同的簽訂及履行將不會對公司業務的獨立性產生重大影響,亦不會因履行該項目而形成業務依賴。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.